On March 4, 2026, Passage BIO, Inc. agreed to terminate a lease for 62,000 square feet of laboratory space, paying a termination fee of approximately $4.8 million. This decision follows a prior restructuring and anticipates operations being funded through early 2027; it is significant for the company.